Form 4: Lane Michael reports multiple insider transactions in IDXX
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Lane Michael reported multiple insider transaction types in a Form 4 filing for IDXX. The filing lists transactions totaling 10,810 shares at a weighted average price of $629.35 per share. Following the reported transactions, holdings were 1,101 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1,092 shares exercised/converted
Mixed
14 txns
Insider
Lane Michael
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 367 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 204 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 220 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 301 | $0.00 | -- |
| Exercise | Common Stock | 204 | $0.00 | -- |
| Exercise | Common Stock | 220 | $0.00 | -- |
| Exercise | Common Stock | 301 | $0.00 | -- |
| Exercise | Common Stock | 367 | $0.00 | -- |
| Tax Withholding | Common Stock | 221 | $629.35 | $139K |
| Grant/Award | Non-Qualified Stock Option (right-to-buy) | 5,361 | $0.00 | -- |
| Grant/Award | Incentive Stock Option (right-to-buy) | 162 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 1,262 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 1,620 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 1,101 shares (Direct);
Common Stock — 7,356.944 shares (Direct);
Non-Qualified Stock Option (right-to-buy) — 5,361 shares (Direct);
Incentive Stock Option (right-to-buy) — 162 shares (Direct);
Common Stock — 592 shares (Indirect, by spouse)
Footnotes (1)
- Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares. Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer. Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. Includes 367 vested but deferred RSUs. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027. Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027. Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024. Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.
FAQ
What insider transactions did IDEXX (IDXX) executive Michael Lane report?
Michael Lane reported equity compensation activity, including new option and RSU grants plus RSU vesting into common stock. The filing also shows a small share disposition used to cover tax obligations tied to these awards, rather than an open-market sale.
How many stock options did Michael Lane receive in this IDEXX (IDXX) Form 4?
Lane received 5,361 non-qualified stock options and 162 incentive stock options. Footnotes state these options become exercisable in scheduled installments starting February 14, 2027 and February 14, 2030, reflecting long-term, time-based vesting rather than immediately exercisable options.
What restricted stock unit (RSU) grants were disclosed for IDEXX (IDXX) executive Michael Lane?
The filing shows new RSU grants of 1,262 and 1,620 units. Footnotes explain these RSUs will vest in annual installments beginning February 14, 2027 and be deferred into the company’s Deferred Compensation Plan, each ultimately representing one share of IDEXX common stock.